Aluminum and Alzheimer’s Disease

  • Maria Teresa ColominaEmail author
  • Fiona Peris-Sampedro
Part of the Advances in Neurobiology book series (NEUROBIOL, volume 18)


Aluminum (Al) is one of the most extended metals in the Earth’s crust. Its abundance, together with the widespread use by humans, makes Al-related toxicity particularly relevant for human health.

Despite some factors influence individual bioavailability to this metal after oral, dermal, or inhalation exposures, humans are considered to be protected against Al toxicity because of its low absorption and efficient renal excretion. However, several factors can modify Al absorption and distribution through the body, which may in turn progressively contribute to the development of silent chronic exposures that may lately trigger undesirable consequences to health. For instance, Al has been recurrently shown to cause encephalopathy, anemia, and bone disease in dialyzed patients. On the other hand, it remains controversial whether low doses of this metal may contribute to developing Alzheimer’s disease (AD), probably because of the multifactorial and highly variable presentation of the disease.

This chapter primarily focuses on two key aspects related to Al neurotoxicity and AD, which are metabolic impairment and iron (Fe) alterations. We discuss sex and genetic differences as a plausible source of bias to assess risk assessment in human populations.


Neurodegeneration Aluminum Transferrin (Tf) Iron (Fe) Sex differences Glucose homeostasis 


  1. Abu-Taweel GM, Ajarem JS, Ahmad M. Neurobehavioral toxic effects of perinatal oral exposure to aluminum on the developmental motor reflexes, learning, memory and brain neurotransmitters of mice offspring. Pharmacol Biochem Behav. 2012;101(1):49–56.CrossRefPubMedGoogle Scholar
  2. AI-Ashmawy MAM. Prevalence and public health significance of aluminum residues in milk and some dairy products. J Food Sci. 2011;76(3):T73–6.CrossRefGoogle Scholar
  3. Aisen P, Enns C, Wessling-Resnick M. Chemistry and biology of eukaryotic iron metabolism. Int J Biochem Cell Biol. 2001;33(33):940–59.CrossRefPubMedGoogle Scholar
  4. Akatsu H, et al. Transition metal abnormalities in progressive dementias. Biometals. 2012;25(2):337–50.CrossRefPubMedGoogle Scholar
  5. Akiyama H, et al. Long-term oral intake of aluminium or zinc does not accelerate Alzheimer pathology in AβPP and AβPP/tau transgenic mice. Neuropathology. 2012;32(4):390–7.CrossRefPubMedGoogle Scholar
  6. Altmann A, et al. Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol. 2014;75(4):563–73.CrossRefPubMedPubMedCentralGoogle Scholar
  7. Anon. Statement of EFSA on the Evaluation of a new study related to the bioavailability of aluminium in food. EFSA Journal. 2011;9(5):2157.CrossRefGoogle Scholar
  8. Banks WA, et al. Aluminum complexing enhances amyloid β protein penetration of blood–brain barrier. Brain Res. 2006;1116(1):215–21.CrossRefPubMedGoogle Scholar
  9. Barth C, Villringer A, Sacher J. Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods. Front Neurosci. 2015;9Google Scholar
  10. Bayless DW, et al. Sex differences in attentional processes in adult rats as measured by performance on the 5-choice serial reaction time task. Behav Brain Res. 2012;235(1):48–54.CrossRefPubMedGoogle Scholar
  11. Bellés M, et al. Silicon reduces aluminum accumulation in rats: relevance to the aluminum hypothesis of Alzheimer disease. Alzheimer Dis Assoc Disord. 1998;12(2):83–7.CrossRefPubMedGoogle Scholar
  12. Beydoun MA, et al. Apolipoprotein E ε4 allele interacts with sex and cognitive status to influence all-cause and cause-specific mortality in U.S. older adults. J Am Geriatr Soc. 2013;61(4):525–34.CrossRefPubMedPubMedCentralGoogle Scholar
  13. Bielarczyk H, Tomaszewicz M, Szutowicz A. Effect of aluminum on acetyl-CoA and acetylcholine metabolism in nerve terminals. J Neurochem. 1998;70(3):1175–81.CrossRefPubMedGoogle Scholar
  14. Bolognin S, et al. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ1–42 aggregation and toxicity. Int J Biochem Cell Biol. 2011;43(6):877–85.CrossRefPubMedGoogle Scholar
  15. Bondy SC. Low levels of aluminum can lead to behavioral and morphological changes associated with Alzheimer’s disease and age-related neurodegeneration. Neurotoxicology. 2016;52:222–9.CrossRefPubMedGoogle Scholar
  16. Burrell, S.-A.M. & Exley, C., 2010. There is (still) too much aluminium in infant formulas. BMC Pediatrics, 10(1), p.63.Google Scholar
  17. Cannata JB, et al. Role of iron metabolism in absorption and cellular uptake of aluminum. Kidney Int. 1991;39(4):799–803.CrossRefPubMedGoogle Scholar
  18. Caspers ML, Dow MJ, Mei-Jun F, Jacques PS, Kwaiser TM. Aluminum-induced alterations in [3H]Ouabain binding and ATP hydrolysis catalyzed by the rat brain synaptosomal (Na+ + K+)-ATPase? Mol Chem Neuropathol. 1994;22(1):43–55.CrossRefPubMedGoogle Scholar
  19. Colomina MT, et al. Influence of age on aluminum-induced neurobehavioral effects and morphological changes in rat brain. Neurotoxicology. 2002;23(6):775–81.CrossRefPubMedGoogle Scholar
  20. Cornutiu G. The epidemiological scale of Alzheimer’s disease. J Clin Med Res. 2015;7(9):657–66.CrossRefPubMedPubMedCentralGoogle Scholar
  21. Crisponi G, et al. The meaning of aluminium exposure on human health and aluminium-related diseases. Biomol Concepts. 2013;4(1)Google Scholar
  22. Darbre PD. Aluminium, antiperspirants and breast cancer. J Inorg Biochem. 2005;99(9):1912–9.CrossRefPubMedGoogle Scholar
  23. Domingo JL, Gómez M, Colomina MT. Oral silicon supplementation: an effective therapy for preventing oral aluminum absorption and retention in mammals. Nutr Rev. 2011;69(1)Google Scholar
  24. Dua R, Kumar V, Sunkaria A, Gill KD. Altered glucose homeostasis in response to aluminium phosphide induced cellular oxygen deficit in rat. Indian J Exp Biol. 2010;48(7):722–30.PubMedGoogle Scholar
  25. Duggan JM, et al. Aluminium beverage cans as a dietary source of aluminium. Med J Aust. 1992;156(9):604–5.PubMedGoogle Scholar
  26. Esparza JL, et al. Aluminum-induced pro-oxidant effects in rats: protective role of exogenous melatonin. J Pineal Res. 2003;35(1):32–9.CrossRefPubMedGoogle Scholar
  27. Exley C. The pro-oxidant activity of aluminum. Free Radic Biol Med. 2004;36(3):380–7.CrossRefPubMedGoogle Scholar
  28. FAO, Evaluations of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), Geneva, 2006.Google Scholar
  29. Fattoretti P, et al. The effect of chronic aluminum(III) administration on the nervous system of aged rats: clues to understand its suggested role in Alzheimer’s disease. J Alzheimer’s Dis JAD. 2003;5(6):437–44.CrossRefPubMedGoogle Scholar
  30. Fenwick S, et al. In end-stage renal failure, does infection lead to elevated plasma aluminium and neurotoxicity? Implications for monitoring. Ann Clin Biochem. 2005;42(2):149–52.CrossRefPubMedGoogle Scholar
  31. Flaten TP. Geographical associations between aluminium in drinking water and death rates with dementia (including Alzheimer’s disease), Parkinson’s disease and amyotrophic lateral sclerosis in Norway. Environ Geochem Health. 1990;12(1–2, 152):–167.Google Scholar
  32. Gao S, et al. The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch Gen Psychiatry. 1998;55(9):809–15.CrossRefPubMedGoogle Scholar
  33. García T, et al. Evaluation of the protective role of melatonin on the behavioral effects of aluminum in a mouse model of Alzheimer’s disease. Toxicology. 2009;265(1–2):49–55.CrossRefPubMedGoogle Scholar
  34. Giacobini E. Cholinergic function and Alzheimer’s disease. Int J Geriatr Psychiatry. 2003;18(Suppl 1):S1–5.CrossRefPubMedGoogle Scholar
  35. Girbovan C, Plamondon H. Environmental enrichment in female rodents: considerations in the effects on behavior and biochemical markers. Behav Brain Res. 2013;253:178–90.CrossRefPubMedGoogle Scholar
  36. Han S, et al. How aluminum, an intracellular ROS generator promotes hepatic and neurological diseases: the metabolic tale. Cell Biol Toxicol. 2013;29(2):75–84.CrossRefPubMedGoogle Scholar
  37. Harris WR, et al. Speciation of aluminum in biological systems. J Toxicol Environ Health. 1996;48(6):543–68.CrossRefPubMedGoogle Scholar
  38. Higgins GA, et al. Apolipoprotein E and Alzheimer’s disease: a review of recent studies. Pharmacol Biochem Behav. 1997;56(4):675–85.CrossRefPubMedGoogle Scholar
  39. Iglesias-González J, et al. Effects of Aluminium on rat brain mitochondria bioenergetics: an in vitro and in vivo study. Mol Neurobiol. 2016:1–8.Google Scholar
  40. Johnson VJ, et al. Decreased membrane fluidity and hyperpolarization in aluminum-treated PC-12 cells correlates with increased production of cellular oxidants. Environ Toxicol Pharmacol. 2005;19(2):221–30.CrossRefPubMedGoogle Scholar
  41. Jonasson Z. Meta-analysis of sex differences in rodent models of learning and memory: a review of behavioral and biological data. Neurosci Biobehav Rev. 2005;28(8):811–25.CrossRefPubMedGoogle Scholar
  42. Joshi JG. Aluminum, a neurotoxin which affects diverse metabolic reactions. Biofactors. 1990;2(3):163–9.PubMedGoogle Scholar
  43. Joshi JG, et al. Iron and aluminum homeostasis in neural disorders. Environ Health Perspects. 1994;102:207–13.CrossRefGoogle Scholar
  44. Jovanović MD, Jelenković A, Stevanović ID, Bokonjić D, Colić M, Petronijević N, Stanimirović DB. Protective effects of glucose-6-phosphate dehydrogenase on neurotoxicity of aluminium applied into the CA1 sector of rat hippocampus. Indian J Med Res. 2014;139(6):864–72.PubMedPubMedCentralGoogle Scholar
  45. Kaizer RR, Maldonado PA, Spanevello RM, Corrêa MC, Gonçalves JF, Becker LV, Morsch VM, Schetinger MRC. The effect of aluminium on NTPDase and 5′-nucleotidase activities from rat synaptosomes and platelets. Int J Dev Neurosci. 2007;25(6):381–6.CrossRefPubMedGoogle Scholar
  46. Kaneko N, Sugioka T, Sakurai H. Aluminum compounds enhance lipid peroxidation in liposomes: insight into cellular damage caused by oxidative stress. J Inorg Biochem. 2007;101(6):967–75.CrossRefPubMedGoogle Scholar
  47. Kim Y, et al. Aluminum stimulates uptake of non-transferrin bound iron and transferrin bound iron in human glial cells. Toxicol Appl Pharmacol. 2007;220(3):349–56.CrossRefPubMedPubMedCentralGoogle Scholar
  48. Krewski, D. et al., Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide, 2007.Google Scholar
  49. Kumar V, Gill KD. Oxidative stress and mitochondrial dysfunction in aluminium neurotoxicity and its amelioration: a review. Neurotoxicology. 2014;41:154–66.CrossRefPubMedGoogle Scholar
  50. Leterrier JF, et al. A molecular mechanism for the induction of neurofilament bundling by aluminum ions. J Neurochem. 1992;58(6):2060–70.CrossRefPubMedGoogle Scholar
  51. Levy-Lahad E, Tsuang D, Bird TD. Recent advances in the genetics of Alzheimer’s disease. J Geriatr Psychiatry Neurol. 1998;11(2):42–54.CrossRefPubMedGoogle Scholar
  52. Li R, Singh M. Sex differences in cognitive impairment and Alzheimer’s disease. Front Neuroendocrinol. 2014;35(3):385–403.CrossRefPubMedPubMedCentralGoogle Scholar
  53. Liu Y, et al. Memory performance, brain excitatory amino acid and acetylcholinesterase activity of chronically aluminum exposed mice in response to soy isoflavones treatment. Phytother Res. 2010;24(10):1451–6.CrossRefPubMedGoogle Scholar
  54. Malik J, et al. Determination of certain micro and macroelements in plant stimulants and their infusions. Food Chem. 2008;111(2):520–5.CrossRefPubMedGoogle Scholar
  55. Martin RB, Bruce R. In: Yasui M, et al., editors. Mineral and metal neurotoxicology; 1997.Google Scholar
  56. Maynard CJ, et al. Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: implications for Alzheimer β-amyloid pathology. J Inorg Biochem. 2006;100(5–6):952–62.CrossRefPubMedGoogle Scholar
  57. Mazure CM, Swendsen J. Sex differences in Alzheimer’s disease and other dementias. Lancet Neurology. 2016;15(5):451–2.CrossRefPubMedGoogle Scholar
  58. Mićić DV, Petronijević ND, Vucetić SS. Superoxide dismutase activity in the mongolian gerbil brain after acute poisoning with aluminum. Journal of Alzheimer’s disease : JAD. 2003;5(1):49–56.CrossRefPubMedGoogle Scholar
  59. Mitsushima D. Sex differences in the septo-hippocampal cholinergic system in rats: behavioral consequences. Curr Top Behav Neurosci. 2011;8:57–71.CrossRefPubMedGoogle Scholar
  60. Miu AC, et al. A behavioral and histological study of the effects of long-term exposure of adult rats to aluminum. Int J Neurosci. 2003;113(9):1197–211.CrossRefPubMedGoogle Scholar
  61. Mohamd EM, et al. Windows into estradiol effects in Alzheimer’s disease therapy. Eur Rev Med Pharmacol Sci. 2011;15(10):1131–40.PubMedGoogle Scholar
  62. Moore PB, et al. Absorption of aluminium-26 in Alzheimer’s disease, measured using accelerator mass spectrometry. Dement Geriatr Cogn Disord. 2000;11(2):66–9.CrossRefPubMedGoogle Scholar
  63. Muir JL. Acetylcholine, aging, and Alzheimer’s disease. Pharmacol Biochem Behav. 1997;56(4):687–96.CrossRefPubMedGoogle Scholar
  64. Neha S, Dhawan DK. Regulatory role of zinc during aluminium-induced altered carbohydrate metabolism in rat brain. J Neurosci Res. 2012;90(3):698–705.CrossRefGoogle Scholar
  65. Nübling G, et al. Synergistic influence of phosphorylation and metal ions on tau oligomer formation and coaggregation with α-synuclein at the single molecule level. Mol Neurodegener. 2012;7:35.CrossRefPubMedPubMedCentralGoogle Scholar
  66. Ohman LO, Martin RB. Citrate as the main small molecule binding Al3+ in serum. Clin Chem. 1994;40(4):598–601.PubMedGoogle Scholar
  67. Oshiro S, et al. Glial cells contribute more to iron and aluminum accumulation but are more resistant to oxidative stress than neuronal cells. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2000;1502(3):405–14.CrossRefGoogle Scholar
  68. Pauluhn J. Pulmonary toxicity and fate of agglomerated 10 and 40 nm aluminum Oxyhydroxides following 4-week inhalation exposure of rats: toxic effects are determined by agglomerated, not primary particle size. Toxicol Sci. 2009;109(1):152–67.CrossRefPubMedGoogle Scholar
  69. Praticò D, et al. Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. FASEB J Off Publ Feder Am Soc Exp Biol. 2002;16(9):1138–40.Google Scholar
  70. Ribes D, et al. Effects of oral aluminum exposure on behavior and neurogenesis in a transgenic mouse model of Alzheimer’s disease. Exp Neurol. 2008;214(2)Google Scholar
  71. Ribes D, et al. Impaired spatial learning and unaltered neurogenesis in a transgenic model of alzheimer’s disease after oral aluminum exposure. Curr Alzheimer Res. 2010;7(5)Google Scholar
  72. Ridge PG, Ebbert MTW, Kauwe JSK. Genetics of Alzheimer’s disease. Biomed Res Int. 2013;2013:254954.CrossRefPubMedPubMedCentralGoogle Scholar
  73. Riihimäki V, et al. Body burden of aluminum in relation to central nervous system function among metal inert-gas welders. Scand J Work Environ Health. 2000;26(2):118–30.CrossRefPubMedGoogle Scholar
  74. Rondeau V, et al. Aluminum and silica in drinking water and the risk of Alzheimer’s disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort. Am J Epidemiol. 2008;169(4):489–96.CrossRefPubMedPubMedCentralGoogle Scholar
  75. Roses, A.D., 1996. Apolipoprotein E and Alzheimer’s disease a rapidly expanding field with medical and epidemiological consequences. Annals of the New York Academy of Sciences, 802(1 Apolipoprotein), pp.50–57.Google Scholar
  76. Ruipérez F, et al. Pro-oxidant activity of aluminum: promoting the Fenton reaction by reducing Fe(III) to Fe(II). J Inorg Biochem. 2012;117:118–23.CrossRefPubMedGoogle Scholar
  77. Rusina R, et al. Higher aluminum concentration in Alzheimer’s disease after box–cox data transformation. Neurotox Res. 2011;20(4):329–33.CrossRefPubMedGoogle Scholar
  78. Sánchez-Iglesias S, et al. Brain oxidative stress and selective behaviour of aluminium in specific areas of rat brain: potential effects in a 6-OHDA-induced model of Parkinson’s disease. J Neurochem. 2009;109(3):879–88.CrossRefPubMedGoogle Scholar
  79. Schellenberg GD, et al. Genetic linkage evidence for a familial Alzheimer’s disease locus on chromosome 14. Science (New York, NY). 1992;258(5082):668–71.CrossRefGoogle Scholar
  80. Schwalfenberg GK, Genuis SJ. Vitamin D, essential minerals, and toxic elements: exploring interactions between nutrients and toxicants in clinical medicine. Sci World J. 2015;2015:1–8.CrossRefGoogle Scholar
  81. Silva VS, et al. Aluminum accumulation and membrane fluidity alteration in synaptosomes isolated from rat brain cortex following aluminum ingestion: effect of cholesterol. Neurosci Res. 2002;44(2):181–93.CrossRefPubMedGoogle Scholar
  82. Silva VS. Effect of chronic exposure to aluminium on isoform expression and activity of Rat (Na+/K+)ATPase. Toxicol Sci. 2005;88(2):485–94.CrossRefPubMedGoogle Scholar
  83. Simpson J, Kelly JP. An investigation of whether there are sex differences in certain behavioural and neurochemical parameters in the rat. Behav Brain Res. 2012;229(1):289–300.CrossRefPubMedGoogle Scholar
  84. Szutowicz A, et al. Acetyl-CoA metabolism in cholinergic neurons and their susceptibility to neurotoxic inputs. Metab Brain Dis. 2000;15(1):29–44.PubMedGoogle Scholar
  85. Torreilles F, Touchon J. Pathogenic theories and intrathecal analysis of the sporadic form of Alzheimer’s disease. Prog Neurobiol. 2002;66(3):191–203.CrossRefPubMedGoogle Scholar
  86. Ungar L, Altmann A, Greicius MD. Apolipoprotein E, gender, and Alzheimer’s disease: an overlooked, but potent and promising interaction. Brain Imaging Behav. 2014;8(2):262–73.CrossRefPubMedPubMedCentralGoogle Scholar
  87. Van den Bosch G, et al. Determination of iron metabolism-related reference values in a healthy adult population. Clin Chem. 2001;47(8)Google Scholar
  88. Verstraeten SV, et al. Myelin is a preferential target of aluminum-mediated oxidative damage. Arch Biochem Biophys. 1997;344(2):289–94.CrossRefPubMedGoogle Scholar
  89. Vučetić-Arsić S, et al. Oxidative stress precedes mitochondrial dysfunction in gerbil brain after aluminum ingestion. Environ Toxicol Pharmacol. 2013;36(3):1242–52.CrossRefPubMedGoogle Scholar
  90. Walton JR, Wang M-X. APP expression, distribution and accumulation are altered by aluminum in a rodent model for Alzheimer’s disease. J Inorg Biochem. 2009;103(11):1548–54.CrossRefPubMedGoogle Scholar
  91. Wang Z, et al. Chronic exposure to aluminum and risk of Alzheimer’s disease: a meta-analysis. Neurosci Lett. 2016;610:200–6.CrossRefPubMedGoogle Scholar
  92. Ward RJ, Zhang Y, Crichton RR. Aluminium toxicity and iron homeostasis. J Inorg Biochem. 2001;87(1):9–14.CrossRefPubMedGoogle Scholar
  93. Weafer J, de Wit H. Sex differences in impulsive action and impulsive choice. Addict Behav. 2014;39(11):1573–9.CrossRefPubMedGoogle Scholar
  94. WHO, Guidelines for drinking-water quality, Geneve, 2004.Google Scholar
  95. WHO, Aluminium in drinking-water. Background document for development of WHO Guidelines for Drinking-water Quality, Geneva, 2010.Google Scholar
  96. Wilhelm M, Jäger DE, Ohnesorge FK. Aluminium toxicokinetics. Pharmacol Toxicol. 1990;66(1):4–9.CrossRefPubMedGoogle Scholar
  97. Willhite CC, et al. Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts. Critic Rev Toxicol. 2014;44(Suppl 4):1–80.CrossRefGoogle Scholar
  98. Wills MR, Savory J. Aluminum and chronic renal failure: sources, absorption, transport, and toxicity. Crit Rev Clin Lab Sci. 1989;27(1):59–107.CrossRefPubMedGoogle Scholar
  99. Woodburn K, et al. Accumulation and toxicity of aluminium-contaminated food in the freshwater crayfish, Pacifastacus leniusculus. Aquat Toxicol. 2011;105(3–4):535–42.CrossRefPubMedGoogle Scholar
  100. Wu Z, et al. Aluminum induces neurodegeneration and its toxicity arises from increased iron accumulation and reactive oxygen species (ROS) production. Neurobiology of Aging. 2012;33(1):199.e1–199.e12.CrossRefGoogle Scholar
  101. Yellamma K, Saraswathamma S, Kumari BN. Cholinergic system under aluminium toxicity in rat brain. Toxicol Int. 2010;17(2):106.CrossRefPubMedPubMedCentralGoogle Scholar
  102. Yokel RA, McNamara PJ. Aluminium toxicokinetics: an updated minireview. Pharmacol Toxicol. 2001;88(4):159–67.CrossRefPubMedGoogle Scholar
  103. Yokel RA, Allen DD, Meyer JJ. Studies of aluminum neurobehavioral toxicity in the intact mammal. Cell Mol Neurobiol. 1994;14(6):791–808.CrossRefPubMedGoogle Scholar
  104. Yokel RA, et al. Entry, half-life, and desferrioxamine-accelerated clearance of brain aluminum after a single (26) Al exposure. Toxicolog Sci Off J Soc Toxicol. 2001;64(1):77–82.CrossRefGoogle Scholar
  105. Yuan C-Y, Lee Y-J, Hsu G-S. Aluminum overload increases oxidative stress in four functional brain areas of neonatal rats. J Biomed Sci. 2012;19(1):51.CrossRefPubMedPubMedCentralGoogle Scholar
  106. Yumoto S, et al. Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer’s disease. J Inorg Biochem. 2009;103(11):1579–84.CrossRefPubMedGoogle Scholar
  107. Zatta P, et al. The role of metals in neurodegenerative processes: aluminum, manganese, and zinc. Brain Res Bull. 2003;62(1):15–28.CrossRefPubMedGoogle Scholar
  108. Zatta P, et al. Alzheimer’s disease, metal ions and metal homeostatic therapy. Trends Pharmacol Sci. 2009;30(7):346–55.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Maria Teresa Colomina
    • 1
    • 2
    Email author
  • Fiona Peris-Sampedro
    • 1
    • 2
  1. 1.Research in Neurobehavior and Health (NEUROLAB)Universitat Rovira i VirgiliTarragonaSpain
  2. 2.Department of Psychology and Research Center for Behavior Assessment (CRAMC)Universitat Rovira i VirgiliTarragonaSpain

Personalised recommendations